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Summary. We report the successful desensitization 
to cefotaxime in a patient with severe lumbar os-
teomyelitis of unknown bacteriology and hyper-
sentivity to the drug. Desensitization was carried 
out because of the unknown bacteriology, the fa-
vorable response to cefotaxime at that time, and 
hypersensitivity to other antibiotics. On the first 
day the patient received 1 mg cefotaxime intrave-
nously. The dose was increased for 13 successive 
days to 4 g cefotaxime intravenously per day. No 
allergic reaction occurred during densitization or 
within 4 weeks of observation under this therapy. 
Patients with severe infections of unknown bacteri-
ology might benefit from desensitization i f therapy 
with a second-choice antibiotic is impossible. 
Key words: Allergy - Cefotaxime - Cephalosporins 
- Desensitization 
Allergic reactions against /J-lactam antibiotics 
(penicillins, cephalosporins, monobactams, and 
carbapenems) are common causes of morbidity in 
patients treated with antibiotics [5, 9, 15, 18] and 
make the discontinuation of the drug indispens-
able. A second-choice antibiotic may be less effec-
tive and/or more toxic. Moreover, patients with 
a history of allergy to /Mactam antibiotics may 
develop life-threatening infections which require 
treatment with these drugs. Desensitization to pen-
icillins has repeatedly been reported [7, 13, 14, 16, 
19]. Cephalosporins are usually effective alterna-
tives to penicillins in cases of hypersensitivity. 
However, penicillins are often insufficient for rep-
lacing cephalosporins, especially third-generation 
cephalosporins, in allergic patients with severe in-
fections of unknown bacteriology. We could not 
find a single report of successful antigen-specific 
desensitization to cephalosporins in the literature. 
In this case report we report the first successful 
* Dedicated to Prof. Dr. N . Zöllner on the occasion of his 
70th birthday 
desensitization to cefotaxime, a widely used third-
generation cephalosporin, in a patient with hyper-
sensitivity to the drug. 
Materials and methods 
A 51-year-old man with severe lumbar spondylitis 
of unknown bacteriology developed an allergic re-
action with generalized pruritic maculopapular 
skin rash, eosinophilia (1800 cells/mm3) and un-
specific IgE response after 25 days of therapy with 
3 x 2 g cefotaxime (Claforan) daily and after 13 
days of therapy with 3 χ 5 g fosfomycin (Fosfocin) 
daily. After the discontinuation of both antibiotics 
all symptoms disappeared. A separate reexposure 
to fosfomycin 2 days after the disappearance of 
the pruritic skin rash led to the same cutaneous 
reaction. Four days after the disappearance of this 
cutaneous reaction a separate reexposure to cefo­
taxime led to the same pruritic skin rash. A ra-
dioallergosorbent test was not available for fosfo­
mycin or for cefotaxime. On the basis of the criter­
ia of Karch et al. [3], hypersensitivity against cefo­
taxime and fosfomycin was highly probable. 
Desensitization to cefotaxime was decided be­
cause of the following reasons, (a) An antibiotic 
with good penetration into bony tissue and with 
broad spectrum was needed due to the unknown 
bacteriology of the lumbar osteomyelitis, (b) The 
clinical response under cefotaxime was favorable, 
(c) The patient had a history of allergic reaction 
to an unknown antibiotic, probably penicillin, 
many years ago. 
Informed consent was obtained after descrip­
tion of the desensitization method and after expla­
nation of the risks and benefits. The desensitization 
was carried out according to the protocol in Ta­
ble 1 and under inpatient conditions. An intrave­
nous infusion line was established, and emergency 
medications and equipment were at bedside. Nurs­
ing personnel were alerted to the possibility of se­
vere allergic reactions. 
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Table 1. Intravenous desensitization to cefotaxime 
Day Solution A Solution Β Dose 
(ml) (ml) (mg) 
1 0.1-0- 0 1 
2 0.1-0- 0.1 2 
3 0.2-0- 0.2 4 
4 0.4-0- 0.4 8 
5 0.8-0- 0.8 16 
6 1.6-0- 1.6 32 
7 3.0-0- 3.0 60 
8 6.0-0- 6.0 120 
9 10 -0-10 200 
10 20 -0-20 400 
11 8.0-0- 8.0 800 
12 16 -0-16 1600 
13 32 -0-32 3200 
14 40 -0-40 4000 
Solution A : 0.5 g cefotaxime (Claforan) diluted in 50 ml isoton­
ic saline; solution B: 2g cefotaxime diluted in 40 ml isotonic 
saline. A fresh solution of cefotaxime was prepared daily 
Results and discussion 
During desensitization and after 4 weeks of thera­
py with 2 χ 2 g cefotaxime no allergic reaction or 
other complication occurred. The outcome of the 
therapy was successful. 
Cefotaxime is the third-generation cephalo­
sporin with which there has been the most experi­
ence [1 , 5, 6]. It provides a potent, broad spectrum 
of activity against aerobic gram-negative bacteria 
that is markedly greater than that provided by 
first- or second-generation cephalosporins [2] or 
extended-spectrum penicillins [1]. Hypersensitivity 
reactions against cefotaxime have an incidence of 
approximately 10% and include skin rash (1.8%), 
drug fever (0.4%), and eosinophilia (1.3%) [4]. Im­
mediate reactions occur in 0.3% of patients treated 
with cefotaxime [4]. Cross-reactivity of penicillins 
and cephalosporins has been repeatedly reported 
in vitro [8] and in retrospective studies [10, 17]. 
However, in prospective studies the apparent 
cross-reactivity appears remarkably less often [11, 
12] and seems to reflect concurrent but non-cross-
reactive sensitivity in a small number of highly al­
lergic individuals presumably due to IgE antibodies 
to side-chain structures rather than the bicyclic 
core [8, 11]. On this basis the apparent cross-reac­
tivity between cefotaxime, fosfomycin, and per­
haps penicillin (history of allergic reaction probab­
ly to penicillin many years ago) can be explained 
in our patient. Moreover the completely different 
molecular structure of cefotaxime and fosfomycin 
makes a true cross-reactivity impossible. 
This case report demonstrates for the first time 
that antigen-specific desensitization to cephalo­
sporins is possible. Because of the wide use of 
third-generation cephalosporins, especially cefo­
taxime, in severe infections of unknown bacteriolo­
gy and because of the relatively high incidence of 
allergic reactions (10%) [4], many patients may 
benefit from desensitization. Nevertheless, the ben­
efits must be carefully compared with potential 
risks, and therapy with a second-choice antibiotic 
should generally be preferred i f it is possible. Pa­
tients with serious allergic reactions, such as ana­
phylactic shock, agranulocytosis, toxic epidermal 
necrolysis, or fibrosing alveolitis, should be ex­
cluded from desensitization. Moreover, desensiti­
zation must be discontinued immediately if signs 
of such a serious allergic reaction appear. 
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- anti-glomerular basement membrane 
825 
- atherosclerotic vascular 145 
- autoimmune 445,664 
- autoimmune thyroid 221 
- cardiovascular 3 
-cerebrovascular 963 
- coronary heart 963 
- cytomegalic inclusion 270 
-glomerular 840 
- lung 452 
- neoplastic 437 
- peripheral arterial occlusive 134 
- poycystic kidney 150 
- systemic rheumatic 327 
disorder 
- endocrine 933 
- nutritional 963 
diuresis 678 
docosahexaenoic acid 314 
donor 
- cadaveric 621 
- living related 621 
Doppler sonography, transcranial 46 
Doppler ultrasound 466 
dosimetry, space 710 
drug compliance 483 
drug, serotoninergic 963 
Duchenne's muscular dystrophy 247 
ductopenia 191 
duplex sonography 531,654 
dysbetalipoproteinemia, familial 362 
dyslipoproteinemia 834 
dystrophin 247 
eczema, atopic 649 
Ehlers-Danlos syndrome type I V 387 
eicosanoid metabolism 634 
eicosapentaenoic acid 314, 628 




electromyography, needle 351 
electrophoresis, two dimensional 953 
embolism, pulmonary 471 
embolization, endopulmonary 559 
emphysema 98 
encephalomyelitis, experimental allergic 
327 
encephalopathy, hepatic 875 
enteropathy, proteinlosing 568 
epilepsy 574 
epinephrine 628 
equivalent dose 710 
ergometer exercise 461 
erucicacid 802 
erythema nodosum 305 




evaluation study 139 
expert system 139 
extensive metabolizer 1002 
eye muscle 445 
failure 
- hepatorenal 93 
- pulmonary 98 
- renal 93 
-respiratory 177 
fatty acid 21 
- metabolite 763 
-long-chain 610 
Felty's syndrome 168 
fever 616 
fiber 290 
- atrophic 351 
fibrosis 98 
- interstitial 867 
- pulmonary 452 
first-pass metabolism 240 
fish oil 314, 628 





foot, diabetic 466 
formula, iodine-supplemented 133 
foscarnet 398 
F R D A locus 109 
Friedreich's ataxia 109 
fructose 290 
fructose bisphosphatase deficienccy 115 
furosemide 579,622 
G - C S F 168 
gait 208 





gastric emptying 542 
Gaucher's disease 78 
gemfibrozil 74 
German Medullary Thyroid Carccinoma 
Study Group 7 
gland, parathyroid 505 
globulin 
- antihymocyte 102 
- antilymphocyte 102 
glomerular filtration 1010 
- rate 93 
glomerulonephritis 
- membranoproliferative 840 
1019 
- me:sangioproliferative 664 
-postinfectious 827 
- rapidly progressive 825 
glomerulopathy, transplant 840 
glomerulopressin 93 
glomerulosclerosis 834 





- tolerance test 372,547 
glycerol trierucate 802 
glycerol trioleate 802 
goiter 126 
-multinodular 552 
gonadotropin-releasing hormone 547 
Gottron's acrogeria 387 
graft rejection, chronic 191 
grammatical reasoning 728 
granulocyte-macrophage colony-
stimulating factor 102,168,791 
growth factor 




- platelet-derived 379,861 
-transforming 861,898 
growth hormone 372,547 
Guillain-Barre syndrome 795 
halofantrine 69 
heart failure 281 
heart rate 704 
hemodialysis 537 
hemorrhage, subarachnoid 54,150 
Henoch, Schönlein purpura 564 
heparin 
- intravenous 471 
-subcutaneous 471 
hepatic failure, acute 875 
hepatitis Β 49 
- chronic active 875 
hepatitis C 49, 888 
hepatitis, autoimmune chronic active 875 
hepatocyte culture 21 
hepatorenal reflex 93 
Heymann nephritis 817 
high-pressure liquid chromatography 161 
histiocytosis, non-X 233 
H I V 42,65,310,319,392 
Hodgkin's disease 57 
homocysteine 993 
human leukocyte antigen 221 
Human chorionic gonadotropin 953 
hyaline membrane 177 
3-hydroxy-3-methylglutarylcoenzyme A 
reductase inhibitor 908 
3-hydroxy-3-methylgIutarylcoenzyme A 





hypercapnic ventilatory response 281 
hypercholesterolemia 27,145,172,331, 
908, 939 
hyperemia, reactive 466 
hyperlipidemia 963 
- familial combined 314 
hyperlipoproteinemia 939 
- type III 362 
hyperparathyroidism 
- asymptomatic 505 
-primary 505 
hyperplasia, nodular regenerative 49 
hyperproteinemia 834 




- pulmonary 98 
hyperthyreoidsm 959 
-overt 126 
- subclinical 126 
hypertriglyceridemia 74 
hypoglycemia lactic acidosis 115 
hypoparathyroidism 924 
hypophosphatemia 852 






ileitis terminalis 564 
ileus 568 
illnesses, nonthyroidal 21 
imidazole derivative 933 
immune complex disease 795 
immune system 590 
immunhistochemistry 233 
immunity, antitumor 590 
immunoglobulin A 270 
immunoglobulin Ε 208 
immunoglobulin Μ 270,875 
immunoglobulins G1-G3 270 
immunohistochemistry 247 
immunosuppression 102 
inclusion body myositis 351 
indocyanine green clearance 654 
indomethacin 928 
infant respiratory distress syndrome 177 
infarction, myocardial 57 
infection 480 
- opportunistic 65 
-pneumococcal 1 
infiltrate, inflammatory 351 
inflammation, meningeal 780 
inflammatory bowel disease 286 
injury 
- glomerular 809,815 
- renal parenchymal 815 




interaction, visual vestibular 749 






- (IL-8) 812 
- 2 receptor, soluble 299,537 
-6 664 
interstitial fluid 690 
intolerance, orthostatic 690 
intraocular pressure 700 
inversion illusion 732 
iodine concentration, urinary 13 
ischemia, renal 858 
ischemic heart disease 3,770 
isotretinoin 74 
K+ channel 849 
kala-azar 616 
Kaposi's sarcoma 398 
keratoderma blenorrhagicum 305 
ketoconazole 933 
ketogenesis, hepatic 264 
kidney 93, 678 




laser angioplasty 978 
lecithimcholesterol acyl transferase 
activity 663 
leishmaniasis, visceral 616 
leukemia, acute promyelocyte 774 
leukocyte FBPase 115 





- bilayer 649 
- infusion 634 
- nonsurfactant 177 
lipidmediator 177 
lipodystrophy, generalized 264 
lipoprotein 314, 628, 990 
-(a) 145,993 
- high-density 277, 314,362,406,574, 908, 
913,939,663 
- intermediate-density 145 
- low density 145,172, 990,277,314,331, 
362,406,574, 908,913, 939 
-metabolism 939 
-oxidized 834 





lithotripsy, extracorporeal shock-wave 
882 
lithotripter 882 
livedo reticularis 305 
liver 150 
- cirrhosis 894 
- cyst 93 
-disease 239,416 
- function, quantitative 888 
- graft recipient 191 
1020 
- test 416 
-transplantation 875 
- non-cirrhotic 49 
long-QT syndrome 319 
lower body negative pressure 690 
lung 
- cancer 488 
-edema 177 
-function 67 
- infiltrate 787 
lupus erythematosus 299,327,664, 827 
Lyme disease 620 
lymphangiectasia, intestinal 568 
lymphocyte, human 770 
lymphoma, non-Hodgkin 32 
macroangiopathy 132 
macrophage 810,834 
magnetic resonance imaging 339,780 
major histocompatibility complex 822 
malaria 69 
malignancy 31 
Marfan syndrome 150 
melanocyte growth-stimulating activity 
861 
membrane, mitochondrial 587 
membrane-coating granule 649 






microcirculation, cutaneous 132 
microgravity 678,687,690,700, 704, 725, 
732,749,740 
minimal change/focal sclerosis 808 
MIR '92 project 676, 710 
mitral valve prolapse 150 
mixed connective tissue disease 257,327 
mixed solid-liquid meal 542 
monocarboxylate 843 
monocyte chemoattractant protein 1 815 
monocyte colony-stimulating factor 1 815 
monocyte-macrophage 815 
multidrug resistence 69 
multiple endocrine neoplasia 7,488,505 
muscle volume, extracellular 704 
muscle weakness 351 
mutation 
- Asp200 to Gly 331 
- serine-156 to leucine 172 
myalgia 999 
myasthenia gravis 445 
Mycobacterium bovis 787 
myeloma, multiple 918 
myoadenylate deaminase deficiency 461 
myopathy 999 
- inflammatory 351 
-metabolic 763 
myxedema 27 
n-3 fatty acid 634 
N-acetyl-beta-D-glucosaminidase 972 
Nl-methyl-nicotinamide 843 
Na+ channel, amiloride sensitive 849 
Na++K+-ATPase 286 
Na+/H+ antiport 119 
natriuresis 622,678 
necroses 466 




- idiopathic membranous 808, 822 
-membranous 817 
- primary IgA 823 
nephrotoxicity 153,1010 
nephrotoxin 858 
neurodysfunction, HIV-associated 396 
neurofibromatosis 488 
neuropathy, peripheral 466 
neurosarcoidosis 54 
neutrophil 809,985 
- leukotriene generation 634 
- polymorphonuclear 791 
nitric oxide 985 
nitroxide 93 
nonsteroidal anti-inflammatory drug 928 
norepinephrine 628 
obesity 542,963, 990 
- android 913 
oestrogen 514 
oleic acid 24 
oligoclonal IgG 795 










oxygen radical 177 
oxypurinol 161,240 




parathyroid hormone 505 
- related protein 31 
parenchyma-pyelon index 531 
paroxetine 1002 
patient, immunocompetent 421 
penicillin prophylaxis 1 
pentamidine 310,319 
peptide 416 
peptide, renal natriuretic 678 
performance 
- cognitive 725 
-psychomotor 725 





P H L E C O Study 471 
phosphate 514,1010 
- deprivation 852 
phospholipase 177 
phospholipid, surfactant 177 
plasmapheresis 257 
Plasmodium falciparum 69 
platelet 628,809 
platelet aggregation inhibitor 471 
platelet-activating factor 634 
Pneumocystis carinii pneumonia 310, 319 
pneumocystoma 310 
pneumocyte, type II 452 
point mutation 172 
polyarteritis nodosa, cutaneous 305 
polychondritis, relapsing 305 
polymerase chain reaction 172,888 
polymorphism, genetic 277,362,1002 





poor metabolizer 1002 
porpranolol 654 






Propionibacterium acnes 644 
prostacyclin analogue 257 
protease 177 




- guttata, acute 634 
P T C A 524 
P T H secretion 505 
PTH-related protein 505 
pulmonary arteritis, primary 559 
pyridoxal 5'-phosphate 993 
pyridoxine 993 
QT-interval 319 
radiation therapy 57 
Raynaud's phenomenon 257 
receptor 
- epidermal growth factor 898, 903 
- neck position 749 
recombinant tissue-type plasminogen 
activator 323 
reentry tachycardia 519 
reflex, vestibulo-ocular 740 
R E M sleep 718 
renal autoimmune disease 817 
renal disease 
- chronic 834, 867 
- end-stage 339,537 
- acute 435, 861 
renal insufficiency 830 
renal transplant failure 531 
renin 628 




rheumatoid arthritis 664 
1021 
rheumatology 139 
r h G M - C S F 791 
ribose side effect 770 
rotating chair 757 
rotation, eccentric 757 
rt-PA 323 
salt balance 622 
salt restriction 990 
sarcoidosis 387 
sarcoma, soft tissue 339 
scleroderma 257 








serotonin reuptake inhibitor, selective 
1002 
serotonin type 3 receptor antagonist 659 
sertraline 1002 
single strand conformational 
polymorphism 331 
skin 
- lesion, inflammatory 634 
-prick test 208 
- surface pH 644 
- tumor 233 
sleep regulation 718 
small airway collapse 177 
smoking passive 67 
sodium 
- retention, proximal tubular 894 
- renal 622 
software, standard analysis 600 
soluble intercellular adhesion molecule 1 
806 
sonography, three-dimensional 226 
space mission, Russion-German 675 
space sickness 732 
spaceflight 676 
sperm cervical mucus penetration-test 
483 





Staphylococcus aureus 780 
static exercise 704 
steroid biosynthesis 933 
streptokinase 795 
stress, cortisol-associated 678 
stroke 3 
substance Ρ 93 
succinate 843 
sulfate 843 
superoxide anion 985 
supersaturation 423 
synapse, neuromuscular 445 
syndrome 
- diabetic foot 466 
- hemophagocytic 620 
-nephrotic 834 
- premature aging 387 
Τ lymphocyte 102 
T-cell rceptor gene 822 
T-suppressor 590 
tachycardia, atrial 519 




- hormonal replacement 406 
- immunosuppressive 153, 351 
- low-dose thrombolytic 323 
thrombocytopenia 802 
- immune 413 
thrombophlebitis, superficial 559 
thrombosis 
- pulmonary arterial 559 
- thrombosis, venous 471 
thymidine kinase 918 
thyroid 
-hormone 13 
- autoimmunity 79,221 
- binding inhibitory immunoglobulin 552 
- carcinoma, medullary 7 
- disorder, subclinical 126 
- gland volume 13 
- neoplasms 898 
- nodule, benign 898 
- peroxidase 221 
- stimulating hormone 126,221,367, 552 
thyroperoxidase 221 
thyrotrophin 27,367 
thyrotropin-releasing hormone 126,547 
thyroxine 21,126,221,552 
thyroxine-binding globuline 126 
tissue hydration 687 
tissue thickness 687 
torasemide 579 
torque, transversal 208 
torsion, ocular 740 
transformation, lymphoblastic 591 
transforming growth factor-alpha 903 
transplantation 
-cardiac 524 
- heart 435 
-kidney 621,840 
-liver 191,435 
- lung 98 
-renal 339 
tri-iodothyronine 221 
trial, clinical 572 




tubular atrophy 867 
tubular function 972 
tubular necrosis, acute 531,861 
tubular toxicity, induced 855 
tubule transport, renal 849 
tubule 
- proximal 852 
-renal 858 
tumor 
- cachexia 37 
- marker 437 
- necrosis factor 37,177,299 
- suppressor gene 488 
-colorectal 903 
- trophoblastic 953 
ultrasound imaging, three-dimensional 
226 
unstable tracking task 729 
urodilatin 435, 678 
vaccine, pneumococcal 1 
vacuole, rimmed 351 
vanishing bile duct syndrome 191 
varicella 421 
vascular disease, peripheral 362 
vasculitis 
-cerebral 613 
- leukocytoclastic 305 
- primary systemic 825 
vasodilation, peripheral 894 
vector, gravitoinertial 757 
vertical, subjective 757 
verticality 732 
vestibular system 757 
virus, varicella-zoster 421 
vitamin C 3 
- supplementation 993 
von Hippel-Lindau syndrome 488 
waist-to-hip-ratio 913 
water 
- immersion 894 
- loss 649,687 
Wechsler Memory Scale 367 
Wegener granulomatosis 613 
weight loss 37 
weight reduction 963 
weightlessness 678,690,704,725,732,740 
Western blot 270, 445 
Wilms' tumor 488 
Wilon's disease 875 
Wolff-Parkinson-White syndrome 519 
xanthoma disseminatum 233 
xanthomatosis, normocholesterolemic 
233 
xenobiotic 843 
xylitol 290 
zidovudine 392 
zinc 537 
